Report - Newsletter Gynäkologie 04-2018 - helios-gesundheit.de · Studie AGO-Ovar -2.31 OReO Patienten Rezidivierendes Ovarial- , Tuben- oder Pertinonealkarzinom Therapie Erhaltungstherapie

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form